欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号HR/H/0103/001
药品名称Bloxazoc 25 mg tablete s produljenim oslobađanjem
活性成分
    • METOPROLOL SUCCINATE 23.75 mg
剂型Prolonged-release tablet
上市许可持有人KRKA-FARMA d.o.o. Radnička cesta 48 10000 Zagreb, Croatia
参考成员国 - 产品名称Croatia (HR)
Bloxazoc 25 mg tablete s produljenim oslobađanjem
互认成员国 - 产品名称
    • Greece (GR)
    • Germany (DE)
    • Denmark (DK)
    • Sweden (SE)
    • Norway (NO)
      Bloxazoc
    • Finland (FI)
    • Poland (PL)
      Bloxazoc
    • Latvia (LV)
      Metazero 23,75 mg ilgstošās darbības tabletes
    • Lithuania (LT)
      Metazero 23,75 mg pailginto atpalaidavimo tabletės
    • Estonia (EE)
      BLOXAZOC 25
    • Hungary (HU)
      BLOXAZOC 25 mg retard tabletta
    • Bulgaria (BG)
      Bloxazoc
    • Cyprus (CY)
    • Czechia (CZ)
      Bloxazoc 25 mg
    • Romania (RO)
      BLOXAZOC 25 mg comprimate cu eliberare prelungită
    • Slovakia (SK)
      Bloxazoc 25 mg tablety s predĺženým uvoľňovaním
    • Slovenia (SI)
    • Iceland (IS)
许可日期2015/10/21
最近更新日期2023/11/20
药物ATC编码
    • C07AB02 metoprolol
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase